Anticipation Grows for Ascentage Pharma's Upcoming Financial Results

Author: Kelly Martin Updated: 03-12-2025 09:01 AM

Ascentage Pharma's Imminent Financial Report

Ascentage Pharma, known for its dedication to addressing global unmet medical needs, particularly in hematological malignancies, is gearing up for an important occasion. The biopharmaceutical company will announce its full year 2024 financial results and provide a corporate update on March 27, 2025, at 7:00 am EDT / 7:00 pm HKT.

Invitation to Investors and Analysts

The management team at Ascentage Pharma cordially invites analysts and investors to participate in a conference call and audio webcast presentation. This interactive session will feature a question and answer segment, encouraging engagement from the attendees.

Conference Call Details

The English conference call and accompanying webcast are scheduled for March 27, 2025, at 8:00 am EDT / 8:00 pm HKT. Interested participants are encouraged to register in advance to secure their local or toll-free phone numbers and personal PINs.

Chinese Investor Event

In addition to the English session, Ascentage Pharma will host a Chinese (Mandarin) investor event on March 28, 2025, at 9:30 am HKT (9:30 pm EDT on March 27, 2025). This session will also allow for simultaneous participation through a conference call and webcast.

Webcast Replay Availability

For those who cannot attend the live sessions, the webcast replays for both the English and Chinese conference calls will be available on the Ascentage Pharma website. The recordings will remain accessible for 30 days, allowing stakeholders to catch up on the essential updates.

Company Overview

Ascentage Pharma is dedicated to discovering, developing, and commercializing innovative therapies to meet significant medical needs across the globe. Focusing primarily on hematological malignancies, the company has secured its presence on major stock exchanges, being listed on the Main Board of the Stock Exchange of Hong Kong Limited and the Nasdaq Global Market under the ticker symbol 'AAPG.'

Contact Information

For inquiries, stakeholders can reach out to:
Investor Relations
Hogan Wan, Head of IR and Strategy
Email: Hogan.Wan@ascentage.com
Phone: +86 512 85557777

Stephanie Carrington
Email: Stephanie.Carrington@icrhealthcare.com
Phone: (646) 277-1282

Media Relations
Sean Leous
Email: Sean.Leous@icrhealthcare.com
Phone: (646) 866-4012

Frequently Asked Questions

What is the date of Ascentage Pharma’s financial report?

Ascentage Pharma will release its financial results on March 27, 2025.

What time will the conference calls begin?

The English conference call will start at 8:00 am EDT and the Mandarin event at 9:30 am HKT.

How can I participate in the conference calls?

Participants must register in advance to obtain access numbers and PINs for the calls.

Where can I find the webcast replay?

The replay of both conference calls will be available on the Ascentage Pharma website for 30 days.

What are the core areas of Ascentage Pharma's focus?

Ascentage Pharma primarily focuses on developing therapies for hematological malignancies.

About The Author

Hello Kelly Martin here, a financial and publicly traded company specialist committed to writing with clarity and sage advice. Having a wealth of experience and a thorough grasp of corporate dynamics and the financial environment, my main goal in writing blog posts and articles is to provide insightful analysis together with useful guidance. My objective is to arm readers with the information they need to comprehend the complexities of publicly traded companies and make wise financial decisions.

Writing for several financial blogs has let me interact with a wide range of readers, from novice investors to seasoned pros looking for fresh perspectives. My goal is to make corporate analysis and finance understandable and interesting so you may confidently negotiate the intricacies of the financial world. I appreciate you traveling with me toward success and financial literacy.

Contact Kelly Martin privately here. Or send an email with ATTN: Kelly Martin as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.